Literature DB >> 20562658

Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Manu S Goyal1, Christopher L Hallemeier, Gregory J Zipfel, Keith M Rich, Robert L Grubb, Michael R Chicoine, Christopher J Moran, DeWitte T Cross, Ralph G Dacey, Colin P Derdeyn.   

Abstract

OBJECTIVE: To define the clinical characteristics and outcome of patients with idiopathic stenosis or occlusion of the basal arteries, without moyamoya collateral vessel formation.
METHODS: We identified patients who presented to our institution from 1996 to 2005 with occlusive disease of the distal internal carotid artery or the proximal middle or anterior cerebral arteries demonstrated by digital subtraction cerebral angiography. We excluded those with evidence of atherosclerotic disease, systemic vasculitis, moyamoya phenomenon, or any other condition that could otherwise explain their arterial occlusive disease. Medical records were reviewed for presenting symptoms and clinical characteristics. Outcome was determined from chart review and phone interviews.
RESULTS: Twelve patients were identified. All presented with transient ischemic attack or stroke. Eleven were women. Age at presentation ranged from 34 to 71 years. Nine had a history of hypertension; 5 had unilateral intracranial disease. Recurrent stroke on medical therapy occurred in none of the 5 during an average follow-up of 29 months. Seven had bilateral disease. Ischemic stroke occurred between 2 and 107 months after the initial event in 5 of 8 medically treated hemispheres. Moyamoya collateral vessels developed in 1 patient as shown on follow-up angiography.
CONCLUSION: The clinical features and outcome of these patients are similar to those reported in large case series of North American patients with moyamoya phenomenon. These data suggest a common etiology for the basal arterial occlusive process and a variable ability to form moyamoya collateral vessels.

Entities:  

Mesh:

Year:  2010        PMID: 20562658      PMCID: PMC3285483          DOI: 10.1227/01.NEU.0000371977.55753.DE

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  29 in total

Review 1.  Moyamoya disease.

Authors:  M Fukui; S Kono; K Sueishi; K Ikezaki
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

2.  Isolated symptomatic stenosis of the middle cerebral artery in younger adults. A clinical and ultrasonic follow-up study of eight patients.

Authors:  V U Becker; B Eckert; A Thie
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

3.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

4.  Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease.

Authors:  M Yamamoto; M Aoyagi; S Tajima; H Wachi; N Fukai; Y Matsushima; K Yamamoto
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

5.  Angiogenic factors in moyamoya disease.

Authors:  T Yoshimoto; K Houkin; A Takahashi; H Abe
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

6.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

7.  Cerebral circulation and metabolism in adults' moyamoya disease--PET study.

Authors:  W Taki; Y Yonekawa; A Kobayashi; M Ishikawa; H Kikuchi; S Nishizawa; Y Yonekura; S Tanada; H Fukuyama
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

8.  Risk factors of moyamoya disease in Canada and the USA.

Authors:  S J Peerless
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

9.  Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination.

Authors:  W J Jones; L S Williams; J F Meschia
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

10.  Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study.

Authors:  K Ikezaki; T Matsushima; Y Kuwabara; S O Suzuki; T Nomura; M Fukui
Journal:  J Neurosurg       Date:  1994-12       Impact factor: 5.115

View more
  3 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

Review 2.  Research on intracranial atherosclerosis from the East and west: why are the results different?

Authors:  Jong S Kim; David Bonovich
Journal:  J Stroke       Date:  2014-09-30       Impact factor: 6.967

Review 3.  A critical appraisal of bypass surgery in moyamoya disease.

Authors:  Michael Moussouttas; Igor Rybinnik
Journal:  Ther Adv Neurol Disord       Date:  2020-05-26       Impact factor: 6.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.